Isolation of a human prostate carcinoma cell line (DU 145).
about
P1343
A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancerComparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling dataEvidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cellsA highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissueIdentification of the phosphatidic acid phosphatase type 2a isozyme as an androgen-regulated gene in the human prostatic adenocarcinoma cell line LNCaPInvolvement of Cyr61 in growth, migration, and metastasis of prostate cancer cellsActivation of the RalGEF/Ral pathway promotes prostate cancer metastasis to boneClinical and experimental progression of a new model of human prostate cancer and therapeutic approachChanges in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancerInvestigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma.Coherent expression chromosome cluster analysis reveals differential regulatory functions of amino-terminal and distal parathyroid hormone-related protein domains in prostate carcinomaEmerging mechanisms of resistance to androgen receptor inhibitors in prostate cancerTumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces.2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/εMxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cellsAndrogen receptor specifically interacts with a novel p21-activated kinase, PAK6Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factorAndrogens upregulate Cdc25C protein by inhibiting its proteasomal and lysosomal degradation pathwaysRole for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cellsmiR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cellsThe type 2 anti-Müllerian hormone receptor has splice variants that are dominant-negative inhibitorsThe aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cellsCharacterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancerMigration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysisPlakophilin-associated RNA-binding proteins in prostate cancer and their implications in tumor progression and metastasis.Efficient intracellular delivery of molecules with high cell viability using nanosecond-pulsed laser-activated carbon nanoparticles.Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency.LHRH-conjugated lytic peptides directly target prostate cancer cells.Estimation of kinetic cell-cycle-related gene expression in G1 and G2 phases from immunofluorescence flow cytometry data.Dynamics of prostate cancer cell invasion studied in vitro by NMR microscopy.Simultaneous detection of cyclin B1, p105, and DNA content provides complete cell cycle phase fraction analysis of cells that endoreduplicate.A D-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization.Identification of novel androgen-responsive genes by sequencing of LongSAGE librariesConstruction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter/enhancer.Targeting HOX transcription factors in prostate cancerProbing sequence variation in the receptor-targeting domain of feline leukemia virus envelope proteins with peptide display libraries.Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodiesIncreased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancerNovel biomarkers for prostate cancer including noncoding transcripts.
P2860
Q21136388-96872972-49E7-4296-B921-8A95D336F10BQ21266587-DE25A47E-F1A5-49EC-8C46-A160E93BA433Q24292284-0A91B7B8-B76E-443E-831E-DBA37691F547Q24299110-EA905C2C-8F2E-4A89-A056-1AA1332A58DDQ24310831-950BEB1C-C1A2-47F0-9A69-6B918930C033Q24655999-6A4E859C-F03C-48D5-B274-A23AB05442D8Q24681479-24A4A2E2-93FA-436E-9A2E-DCD52C79F5B1Q24685731-77417788-729B-4DE9-9BD7-4DAB26B96063Q24807354-F9D8ACCD-AA8C-4D2A-A21B-C1A4AF8DA961Q24815816-0B4B453C-07DA-465A-959D-432B1784C380Q25257305-28DC31C5-567F-494C-85DE-1575B5E5D512Q26777310-73F5DF06-FE6A-4302-848E-9C017C1178A7Q27316928-3DE4CA19-E79D-4CA8-8025-52C5B1F619BCQ27677250-EF3C277B-7AB2-45B2-9775-DD5072C1DF5EQ28188728-3764BD6E-9D01-4B95-8AE3-DA1E956C5F97Q28208123-E04AF095-C1CB-4D60-A77C-A8DD4129A1AAQ28345285-25CA5E9F-1C95-4095-B513-9C1F137FB0A7Q28397032-F2ADF7DA-7D26-4D6B-ADDF-55E5DE815C4DQ28472519-10360B99-A4EF-4455-BDAC-C19BB43E7E57Q28473023-1F7F1561-5223-48CF-BAEB-F410566FBCB5Q28511212-7DB93445-9A3F-438D-9A47-0DAA6106DD15Q28538111-373D0537-0C83-44B4-B24A-C71687AA3C9DQ28539356-AD2EE61B-2FDE-41C3-883B-821AB4338F82Q29615074-AF0A89A6-53FE-41BD-8BEE-8EB3204B4CF0Q30009601-AED520A5-21E2-4DA8-A3DE-6CF10698376AQ30418514-8CD4D217-75EC-4D3C-9751-A5287CC7B991Q30438661-7FCFFC3D-6CAF-42CA-8EA0-57D004015281Q30485711-8A22EF87-6B52-4602-9ACD-DA85E089FDA7Q30497581-3D4DEC74-7262-44A9-894C-CD851730A2FEQ30559824-7F4916CC-8A31-456F-B1D3-1F348F6CDE48Q30580492-585ACB38-C4BC-4552-B449-69D9F7D889BFQ30655666-57A66158-A23C-4CCE-B21A-184CEC355F82Q30742270-F475C9DE-CD02-4D1F-BA5D-9CAE1CE8BED0Q30875945-9F0B52DE-E8DD-4C15-9B35-C113FA831FEBQ31147626-8680FC7E-135E-438B-8290-C0278C1F682FQ31150248-289206A4-3B66-4F31-92D0-AE7B8E25B0D4Q33210857-CB5C6D88-215F-4400-B0C6-8DD00F32E59EQ33322420-5A747948-7868-46C9-A9B5-D4A36CF18E02Q33382065-117D6128-0C0F-4674-A7F5-C6B1EA9DA889Q33515231-01B2B9C6-42C1-41BE-BD24-4A517C581A3F
P2860
Isolation of a human prostate carcinoma cell line (DU 145).
description
1978 nî lūn-bûn
@nan
1978 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի մարտին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Isolation of a human prostate carcinoma cell line (DU 145).
@ast
Isolation of a human prostate carcinoma cell line (DU 145).
@en
Isolation of a human prostate carcinoma cell line
@nl
type
label
Isolation of a human prostate carcinoma cell line (DU 145).
@ast
Isolation of a human prostate carcinoma cell line (DU 145).
@en
Isolation of a human prostate carcinoma cell line
@nl
prefLabel
Isolation of a human prostate carcinoma cell line (DU 145).
@ast
Isolation of a human prostate carcinoma cell line (DU 145).
@en
Isolation of a human prostate carcinoma cell line
@nl
P2093
P356
P1476
Isolation of a human prostate carcinoma cell line (DU 145).
@en
P2093
D D Mickey
D F Paulson
G H Mickey
H Wunderli
P2860
P304
P356
10.1002/IJC.2910210305
P4510
P577
1978-03-01T00:00:00Z